News brief­ing: Ve­rastem CMO ex­its two weeks af­ter join­ing com­pa­ny; Ther­mo Fish­er inks $550M M&A deal

Two weeks af­ter join­ing Ve­rastem On­col­o­gy as chief med­ical of­fi­cer, Frank Neu­mann is leav­ing the com­pa­ny for an­oth­er job.

Neu­mann had joined Ve­rastem af­ter leav­ing blue­bird bio, which sur­pris­ing­ly split in­to two com­pa­nies last week, one in on­col­o­gy and one in rare dis­eases. It’s not yet clear to where Neu­mann is head­ed next, but he not­ed in a state­ment that Ve­rastem’s da­ta and strat­e­gy were “tru­ly ex­cit­ing.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.